The International Immunotherapy Society for Fungal Diseases
The treatment of invasive fungal diseases is unsatisfactory because of high morbidity and mortality despite antifungal therapy. These patients are often immunocompromised, and improvements in treatment outcome are likely to require immune therapy. To promote immune therapies against fungal diseases, the International Immunotherapy Society for Fungal Diseases was organized.
Authors
- Arturo Casadevall
- Frank L. van de Veerdonk
- Dimitrios P. Kontoyiannis
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Johns Hopkins University (US)
- Radboud University Nijmegen (NL)
- University Medical Center (US)
- Radboud University Medical Center (NL)
Publication Details
- Journal
- Antimicrobial Agents and Chemotherapy
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1128/aac.01774-25
- Primary Topic
- Fungal Infections and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00